<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Prospective Grant of Exclusive License: The Development of Anti-mesothelin Targeted Immunotoxins for the Treatment of Cancer</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Prospective Grant of Exclusive License: The Development of Anti-mesothelin Targeted Immunotoxins for the Treatment of Cancer</h1>
    <p class="timestamp">Published: 2012-02-14 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>This is notice, in accordance with 35 U.S.C. 209(c)(1) and 37 CFR Part 404.7(a)(1)(i), that the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an exclusive patent license to practice the inventions embodied in US Patent application 61/535,668 entitled "Pseudomonas Exotoxin A with Less Immunogenic B Cell Epitopes" [HHS Ref. E-263-2011/0-US-01], US Patent application 61/495,085 entitled "Pseudomonas Exotoxin A with Less Immunogenic T Cell Epit...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, National Institutes of Health</p>
    <p><strong>Document Number:</strong> 2012-3410</p>
    <p><strong>Publication Date:</strong> 2012-02-14</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2012/02/14/2012-3410/prospective-grant-of-exclusive-license-the-development-of-anti-mesothelin-targeted-immunotoxins-for">https://www.federalregister.gov/documents/2012/02/14/2012-3410/prospective-grant-of-exclusive-license-the-development-of-anti-mesothelin-targeted-immunotoxins-for</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2012-3410</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
